NGS Streamlines Biomarker Testing in Solid Tumors

Chen, PharmD, MS, BCOP, CPP, discusses how next-generation sequencing improves biomarker testing and treatment planning in solid tumors.

Experts involved: Traina, MD, FASCO; Demetria Smith-Graziani, MD, MPH; Mark Agulnik, MD; Mrinal M. Guckerman, MD
Additional contributors: Naval G. Daver, MD; Jessica Altman, MD; Amir T. Firoz, MD; Joshua Zeidner, MD
Further research by: Estelamari Rodriguez, MD, MPH; Millie Das, MD; Ruham Nasany, MD
Key findings presented by: Anne Chiang, MD, PhD; J. Douglas Miles, MD, PhD, FAAN; Suma Satti, MD
Insights from: Zev A. Shah, MD, FASCO; Syma Iqbal, MD; Jennifer R.

No specific quotes available in the provided text.

Author's summary: Next-generation sequencing improves biomarker testing.

Oncology Nursing News — 2025-10-27